12:31 PM EST - Microbix Biosystems Inc. : Announced the issuance of stock options under its shareholder-approved 2018 stock option plan, as part of its compensation programs to incentivize and retain its board of directors, executives, and managers. In consultation with the CEO and CFO, the Microbix Board of Directors has approved the issuance of 1,920,000 options in accordance with the terms of the Stock Option Plan. The options are exercisable at a price of $0.23 per share, as determined by the closing price of the TSX on February 21, 2019. Each option will vest and be exercisable after three years and have a total life of five years. The stock option grants form part of the total remuneration package for the recipients and are subject to TSX approval. Microbix Biosystems Inc.
shares T.MBX are trading down $0.01 at $0.25.
